These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5316197)

  • 1. Studies on the central effects of bulbocapnine.
    Loizzo A; De Carolis AS; Longo VG
    Psychopharmacologia; 1971; 22(3):234-49. PubMed ID: 5316197
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modifications of cortical excitability and of various subcortical structures during catalepsy induced with bulbocapnine in cats].
    PASSOUANT P; PASSOUANT-FONTAINE T; CADILHAC J
    C R Seances Soc Biol Fil; 1955 Dec; 149(23-24):2185-7. PubMed ID: 13317329
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice.
    Florio V; Longo VG
    Physiol Behav; 1971 Apr; 6(4):465-6. PubMed ID: 5148760
    [No Abstract]   [Full Text] [Related]  

  • 4. The EEG effects of dopa in the rabbit depending upon the level of brain-stem section.
    Kadzielawa K
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):310-21. PubMed ID: 4597220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of peripheral serotonin antagonists on changes in the background bioelectric activity of the rat cerebral cortex caused by 5-hydroxytryptophan].
    Vysokovskiĭ TM; Gilev AP
    Biull Eksp Biol Med; 1970 Nov; 70(11):77-81. PubMed ID: 5312920
    [No Abstract]   [Full Text] [Related]  

  • 6. Injections of bulbocapnine into the cerebral ventricles of cats.
    FELDBERG W; SHERWOOD SL
    Br J Pharmacol Chemother; 1955 Sep; 10(3):371-4. PubMed ID: 13269717
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electroencephalographic analysis of the central action of pyrazidol].
    Roshchina LF
    Farmakol Toksikol; 1976; 39(4):397-402. PubMed ID: 1088409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurophysiologic study of the psychomotor effect of a drug: apropos of bulcocapnine catatonia].
    Borenstein P; Gekière F; Aleonard P; Gruet-Masson J; Allègre G
    Sem Hop; 1969 Apr; 45(19):1247-57. PubMed ID: 4306997
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonism of tremorine-induced tremor by serotoninergic agents in mice. Interactions with levodopa.
    Rodríguez R
    Life Sci I; 1972 Jun; 11(11):535-44. PubMed ID: 4540331
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of imipramine on the central effects of dihydroxyphenylalanine.
    Kadzielawa K; Widy E
    Neuropharmacology; 1970 Sep; 9(5):467-80. PubMed ID: 5477432
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the dopaminergic system in the cataleptogenic action of bulbocapnine.
    Massotti M; Longo VG
    J Pharm Pharmacol; 1979 Oct; 31(10):691-5. PubMed ID: 41042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of diprazin and dimedrol on the bathmotropic effect of strophanthin].
    Gubarev EA; Buttseva TA
    Farmakol Toksikol; 1970; 33(5):560-3. PubMed ID: 5493215
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the effects of imipramine and desipramine on single cortical neurones.
    Bradshaw CM; Roberts MH; Szabadi E
    Br J Pharmacol; 1973 Jun; 48(2):358P-359P. PubMed ID: 4733751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Frequency spectrum analysis of the electrical activity of the brain in the rat as affected by ketamine].
    Vorob'ev VV; Gal'chenko AA
    Farmakol Toksikol; 1988; 51(1):26-8. PubMed ID: 3129304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of catatonigenic substances. 6. Conclusion].
    Stille G
    Arzneimittelforschung; 1971 Jul; 21(7):997-1003. PubMed ID: 5109518
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain areas associated with bulbocapnine catalepsy.
    Tseng LF; Wei E; Loh HH
    Eur J Pharmacol; 1973 Jun; 22(3):363-6. PubMed ID: 4738904
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychopharmacologic effects of some cholinesterase inhibitors in comparison with imipramine.
    Fekete M; Kürti M
    Psychopharmacologia; 1970; 18(3):238-48. PubMed ID: 5530580
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in the effects of hexobarbital in male rats induced by manipulations of monoamines through reserpine or pargyline combined with Dopa or 5-hydroxytryptophane.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1971; 30(5):353-65. PubMed ID: 5316874
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropharmacological comparison of cyclazocine and imipramine.
    Drew WG; White RP
    Pharmacology; 1973; 9(2):65-73. PubMed ID: 4713006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.